Literature DB >> 21753118

A lysosomal lair for a pathogenic protein pair.

Ted M Dawson1, Valina L Dawson.   

Abstract

Parkinson's disease (PD) is a progressive neurodegenerative disorder that affects movement. Although many of the causes of PD remain unclear, a consistent finding is the abnormal accumulation of the protein α-synuclein. In a recent issue of Cell, Mazzuli et al. provide a molecular explanation for the unexpected link between PD and Gaucher's disease, a glycolipid lysosomal storage disorder caused by loss of the enzyme glucocerebrosidase (GBA). They report a reciprocal connection between loss of GBA activity and the accumulation of α-synuclein in lysosomes that establishes a bidirectional positive feedback loop with pathogenic consequences. Understanding how lysosomes are implicated in PD may reveal new therapeutic targets for treating this disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21753118      PMCID: PMC4449726          DOI: 10.1126/scitranslmed.3002808

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN: 1946-6234            Impact factor:   17.956


  34 in total

Review 1.  Recent advances in the genetics of Parkinson's disease.

Authors:  Ian Martin; Valina L Dawson; Ted M Dawson
Journal:  Annu Rev Genomics Hum Genet       Date:  2011       Impact factor: 8.929

Review 2.  Integration of clearance mechanisms: the proteasome and autophagy.

Authors:  Esther Wong; Ana Maria Cuervo
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-11-10       Impact factor: 10.005

Review 3.  Mechanisms of Parkinson's disease linked to pathological alpha-synuclein: new targets for drug discovery.

Authors:  Virginia M-Y Lee; John Q Trojanowski
Journal:  Neuron       Date:  2006-10-05       Impact factor: 17.173

Review 4.  Lysosomal storage disorders and Parkinson's disease: Gaucher disease and beyond.

Authors:  Tamar Shachar; Christophe Lo Bianco; Alessandra Recchia; Christoph Wiessner; Annick Raas-Rothschild; Anthony H Futerman
Journal:  Mov Disord       Date:  2011-05-26       Impact factor: 10.338

Review 5.  Diagnosis and treatment of Parkinson disease: molecules to medicine.

Authors:  Joseph M Savitt; Valina L Dawson; Ted M Dawson
Journal:  J Clin Invest       Date:  2006-07       Impact factor: 14.808

6.  Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase.

Authors:  Alfredo Ramirez; André Heimbach; Jan Gründemann; Barbara Stiller; Dan Hampshire; L Pablo Cid; Ingrid Goebel; Ammar F Mubaidin; Abdul-Latif Wriekat; Jochen Roeper; Amir Al-Din; Axel M Hillmer; Meliha Karsak; Birgit Liss; C Geoffrey Woods; Maria I Behrens; Christian Kubisch
Journal:  Nat Genet       Date:  2006-09-10       Impact factor: 38.330

7.  Accumulation and distribution of α-synuclein and ubiquitin in the CNS of Gaucher disease mouse models.

Authors:  Y H Xu; Y Sun; H Ran; B Quinn; D Witte; G A Grabowski
Journal:  Mol Genet Metab       Date:  2010-12-31       Impact factor: 4.797

8.  Occurrence of Parkinson's syndrome in type I Gaucher disease.

Authors:  O Neudorfer; N Giladi; D Elstein; A Abrahamov; T Turezkite; E Aghai; A Reches; B Bembi; A Zimran
Journal:  QJM       Date:  1996-09

9.  Acid β-glucosidase mutants linked to Gaucher disease, Parkinson disease, and Lewy body dementia alter α-synuclein processing.

Authors:  Valerie Cullen; S Pablo Sardi; Juliana Ng; You-Hai Xu; Ying Sun; Julianna J Tomlinson; Piotr Kolodziej; Ilana Kahn; Paul Saftig; John Woulfe; Jean-Christophe Rochet; Marcie A Glicksman; Seng H Cheng; Gregory A Grabowski; Lamya S Shihabuddin; Michael G Schlossmacher
Journal:  Ann Neurol       Date:  2011-04-06       Impact factor: 10.422

10.  Neuromelanin and Parkinson's disease.

Authors:  C D Marsden
Journal:  J Neural Transm Suppl       Date:  1983
View more
  5 in total

Review 1.  Lysosomal impairment in Parkinson's disease.

Authors:  Benjamin Dehay; Marta Martinez-Vicente; Guy A Caldwell; Kim A Caldwell; Zhenyue Yue; Mark R Cookson; Christine Klein; Miquel Vila; Erwan Bezard
Journal:  Mov Disord       Date:  2013-04-11       Impact factor: 10.338

2.  A GCase chaperone improves motor function in a mouse model of synucleinopathy.

Authors:  Franziska Richter; Sheila M Fleming; Melanie Watson; Vincent Lemesre; Lee Pellegrino; Brian Ranes; Chunni Zhu; Farzad Mortazavi; Caitlin K Mulligan; Pedrom C Sioshansi; Sindalana Hean; Krystal De La Rosa; Richie Khanna; John Flanagan; David J Lockhart; Brandon A Wustman; Sean W Clark; Marie-Françoise Chesselet
Journal:  Neurotherapeutics       Date:  2014-10       Impact factor: 7.620

3.  α-Synuclein accumulation and GBA deficiency due to L444P GBA mutation contributes to MPTP-induced parkinsonism.

Authors:  Seung Pil Yun; Donghoon Kim; Sangjune Kim; SangMin Kim; Senthilkumar S Karuppagounder; Seung-Hwan Kwon; Saebom Lee; Tae-In Kam; Suhyun Lee; Sangwoo Ham; Jae Hong Park; Valina L Dawson; Ted M Dawson; Yunjong Lee; Han Seok Ko
Journal:  Mol Neurodegener       Date:  2018-01-08       Impact factor: 14.195

Review 4.  Current Evidence for a Bidirectional Loop Between the Lysosome and Alpha-Synuclein Proteoforms.

Authors:  Norelle C Wildburger; Anna-Sophia Hartke; Alina Schidlitzki; Franziska Richter
Journal:  Front Cell Dev Biol       Date:  2020-11-17

5.  Lysosomal abnormalities in hereditary spastic paraplegia types SPG15 and SPG11.

Authors:  Benoît Renvoisé; Jaerak Chang; Rajat Singh; Sayuri Yonekawa; Edmond J FitzGibbon; Ami Mankodi; Adeline Vanderver; Alice Schindler; Camilo Toro; William A Gahl; Don J Mahuran; Craig Blackstone; Tyler Mark Pierson
Journal:  Ann Clin Transl Neurol       Date:  2014-06-01       Impact factor: 4.511

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.